Browse by:
Technology

Koopman Hardware family sells land to storage business for $6.6M

Grant Welker |

The family behind Koopman Hardware & Lumber has sold part of its Grafton property and a Whitinsville site for a combined $6.6 million to a national storage facility firm.

Sprawling Westminster commercial building sells for $13M

Grant Welker |

A nearly 700,000-square-foot commercial building off Route 2 in Westminster has sold for $13 million.

Hologic subsidiary lands laughing gas rights

A subsidiary of Marlborough medical device firm Hologic has landed the U.S. and Canadian distribution rights of a Pennsylvania medical equipment manufacturer’s nitrous oxide and oxygen systems.

Biostage eyes FDA application in 2019

Despite just $5.8 million in cash to its name, Holliston organ bioengineering firm Biostage is eyeing a 2019 U.S. Food and Drug Administration application for its esophagus-regenerating device.

Inc. 5000 honors 16 fast-growing Central Mass. firms

Zachary Comeau |

A total of 16 Central Massachusetts companies made Inc. 5000's 2018 list of the 5,000 fastest growing companies in the country.

Worcester State, Nichols form counter-terrorism degree agreement

Grant Welker |

Worcester State University criminal justice majors will be able to get a master's degree in counter-terrorism a year ahead of time under a new agreement with Nichols College in Dudley.

FDA warns Hologic over device's vaginal rejuvenation claims

Zachary Comeau |

Marlborough medical device company Hologic is suspending the marketing and distribution of a vaginal heating device after the company receiving a warning from the U.S. Food and Drug Administration.

Biostage to withdraw SEC registration

Holliston biotech Biostage is seeking to withdraw a registration statement with the SEC filed nearly one year ago after no securities had been issued or sold under the statement.

Worcester biotech to treat bubble boy disease

Mustang Bio's Worcester facility will play a role in a new exclusive partnership with a leading children's medical center to help develop treatments for an immunodeficiency disorder.

Hopkinton biopharmaceutical Spring Bank hopes to raise $37.5M

Hopkinton-based Spring Bank Pharmaceuticals wants to raise $37.5 million to fund clinical trials, studies and research and other corporate purposes.

ADVERTISEMENTS
Copyright 2017 New England Business Media